Its quantification in the blood serum can be helpful for CRC diagnosis and can serve as an indication of the cancer development stage, but current analytic approaches (fluorescence immunoassays, electrochemistry and enzyme-like immunoabsorbent assays (ELISA)) for CEA detection have several disadvantages. This evidence concerns the gene CEACAM5 and cancer.